Business Description
DocCheck AG
ISIN : DE000A1A6WE6
Description
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.59 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 0.49 | |||||
Interest Coverage | 17.55 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.85 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.2 | |||||
3-Year EBITDA Growth Rate | 26.6 | |||||
3-Year EPS without NRI Growth Rate | 19.7 | |||||
3-Year Book Growth Rate | 20.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.83 | |||||
9-Day RSI | 44.35 | |||||
14-Day RSI | 46.5 | |||||
6-1 Month Momentum % | -5 | |||||
12-1 Month Momentum % | -25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 2.16 | |||||
Cash Ratio | 1.11 | |||||
Days Inventory | 55.59 | |||||
Days Sales Outstanding | 46.18 | |||||
Days Payable | 41.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.85 | |||||
Dividend Payout Ratio | 0.76 | |||||
3-Year Dividend Growth Rate | 35.7 | |||||
Forward Dividend Yield % | 5.85 | |||||
5-Year Yield-on-Cost % | 13.67 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 6.79 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.21 | |||||
Operating Margin % | 11.53 | |||||
Net Margin % | 10.23 | |||||
FCF Margin % | 6.32 | |||||
ROE % | 16.09 | |||||
ROA % | 10.36 | |||||
ROIC % | 13.09 | |||||
ROC (Joel Greenblatt) % | 45.99 | |||||
ROCE % | 19.86 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 7.59 | |||||
PE Ratio without NRI | 8.92 | |||||
Shiller PE Ratio | 9.26 | |||||
Price-to-Owner-Earnings | 7.86 | |||||
PEG Ratio | 0.25 | |||||
PS Ratio | 0.77 | |||||
PB Ratio | 1.21 | |||||
Price-to-Tangible-Book | 1.23 | |||||
Price-to-Free-Cash-Flow | 12.24 | |||||
Price-to-Operating-Cash-Flow | 8.04 | |||||
EV-to-EBIT | 4.1 | |||||
EV-to-EBITDA | 3.03 | |||||
EV-to-Revenue | 0.62 | |||||
EV-to-FCF | 9.77 | |||||
Price-to-Projected-FCF | 0.6 | |||||
Price-to-DCF (Earnings Based) | 0.23 | |||||
Price-to-DCF (FCF Based) | 0.88 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.33 | |||||
Price-to-Graham-Number | 0.7 | |||||
Price-to-Net-Current-Asset-Value | 3.73 | |||||
Earnings Yield (Greenblatt) % | 24.39 | |||||
FCF Yield % | 8.15 | |||||
Forward Rate of Return (Yacktman) % | 26.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DocCheck AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 57.538 | ||
EPS (TTM) (€) | 1.16 | ||
Beta | 0.69 | ||
Volatility % | 31.71 | ||
14-Day RSI | 46.5 | ||
14-Day ATR (€) | 0.325606 | ||
20-Day SMA (€) | 8.65 | ||
12-1 Month Momentum % | -25 | ||
52-Week Range (€) | 7.5 - 11.9 | ||
Shares Outstanding (Mil) | 5.07 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DocCheck AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DocCheck AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
DocCheck AG Frequently Asked Questions
What is DocCheck AG(STU:AJ91)'s stock price today?
The current price of STU:AJ91 is €8.55. The 52 week high of STU:AJ91 is €11.90 and 52 week low is €7.50.
When is next earnings date of DocCheck AG(STU:AJ91)?
The next earnings date of DocCheck AG(STU:AJ91) is .
Does DocCheck AG(STU:AJ91) pay dividends? If so, how much?
The Dividend Yield %  of DocCheck AG(STU:AJ91) is 5.85% (As of Today), Highest Dividend Payout Ratio of DocCheck AG(STU:AJ91) was 1.01. The lowest was 0.06. And the median was 0.7. The  Forward Dividend Yield % of DocCheck AG(STU:AJ91) is 5.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |